PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.20%
Revenue growth 1.25-1.5x ADI's 4.38%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
-6.44%
Negative gross profit growth while ADI is at 4.32%. Joel Greenblatt would examine cost competitiveness or demand decline.
-6.41%
Negative EBIT growth while ADI is at 9.13%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-6.41%
Negative operating income growth while ADI is at 9.13%. Joel Greenblatt would press for urgent turnaround measures.
0.69%
Net income growth under 50% of ADI's 10.69%. Michael Burry would suspect the firm is falling well behind a key competitor.
-5.26%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-5.26%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.57%
Share reduction more than 1.5x ADI's 133.16%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-0.27%
Reduced diluted shares while ADI is at 133.16%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
2.54%
Dividend growth of 2.54% while ADI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
4.31%
OCF growth under 50% of ADI's 184.81%. Michael Burry might suspect questionable revenue recognition or rising costs.
-94.07%
Negative FCF growth while ADI is at 297.44%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
137.93%
10Y revenue/share CAGR above 1.5x ADI's 68.47%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
76.91%
5Y revenue/share CAGR above 1.5x ADI's 4.71%. David Dodd would look for consistent product or market expansions fueling outperformance.
71.38%
Positive 3Y CAGR while ADI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
-9.01%
Negative 5Y OCF/share CAGR while ADI is at 213.37%. Joel Greenblatt would question the firm’s operational model or cost structure.
42.84%
3Y OCF/share CAGR under 50% of ADI's 187.90%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
665.18%
10Y net income/share CAGR of 665.18% while ADI is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
548.82%
5Y net income/share CAGR above 1.5x ADI's 184.13%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
257.19%
3Y net income/share CAGR 1.25-1.5x ADI's 173.46%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
128.96%
10Y equity/share CAGR above 1.5x ADI's 42.26%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
49.99%
5Y equity/share CAGR above 1.5x ADI's 7.98%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
98.79%
Positive short-term equity growth while ADI is negative. John Neff sees a strong advantage in near-term net worth buildup.
4.56%
Dividend/share CAGR of 4.56% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
23.92%
Dividend/share CAGR of 23.92% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
29.96%
3Y dividend/share CAGR of 29.96% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-5.71%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
6.77%
Inventory growth well above ADI's 6.04%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.61%
Asset growth at 50-75% of ADI's 9.88%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
5.79%
Positive BV/share change while ADI is negative. John Neff sees a clear edge over a competitor losing equity.
-6.21%
We’re deleveraging while ADI stands at 0.12%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Our R&D shrinks while ADI invests at 2.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
40.00%
SG&A growth well above ADI's 1.90%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.